A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma

Teri N. Kreisl; Weiting Zhang; Yazmin Odia; Joanna H. Shih; John A. Butman; Dima Hammoud; Fabio M. Iwamoto; Joohee Sul; Howard A. Fine

doi:10.1093/neuonc/nor091

A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma

Teri N. Kreisl
, Weiting Zhang
, Yazmin Odia
, Joanna H. Shih
, John A. Butman
, Dima Hammoud
, Fabio M. Iwamoto
, Joohee Sul
, Howard A. Fine

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	13
DOIs	https://doi.org/10.1093/neuonc/nor091
State	Published - Oct 1 2011

Disciplines

Medicine and Health Sciences
Pathology

Access to Document

10.1093/neuonc/nor091License: Unspecified

Cite this

@article{dc78ae9687d8490d9933076e10544952,

title = "A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma",

author = "Kreisl, \{Teri N.\} and Weiting Zhang and Yazmin Odia and Shih, \{Joanna H.\} and Butman, \{John A.\} and Dima Hammoud and Iwamoto, \{Fabio M.\} and Joohee Sul and Fine, \{Howard A.\}",

note = "Neuro Oncol. 2011 Oct;13(10):1143-50. doi: 10.1093/neuonc/nor091. Epub 2011 Aug 24. Clinical Trial, Phase II; Research Support, N.I.H., Intramural",

year = "2011",

month = oct,

day = "1",

doi = "10.1093/neuonc/nor091",

language = "American English",

volume = "13",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma

AU - Kreisl, Teri N.

AU - Zhang, Weiting

AU - Odia, Yazmin

AU - Shih, Joanna H.

AU - Butman, John A.

AU - Hammoud, Dima

AU - Iwamoto, Fabio M.

AU - Sul, Joohee

AU - Fine, Howard A.

N1 - Neuro Oncol. 2011 Oct;13(10):1143-50. doi: 10.1093/neuonc/nor091. Epub 2011 Aug 24. Clinical Trial, Phase II; Research Support, N.I.H., Intramural

PY - 2011/10/1

Y1 - 2011/10/1

UR - https://www.ncbi.nlm.nih.gov/pubmed/21865400

U2 - 10.1093/neuonc/nor091

DO - 10.1093/neuonc/nor091

M3 - Article

VL - 13

JO - Neuro-oncology

JF - Neuro-oncology

ER -

A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma

Disciplines

Access to Document

Other files and links

Cite this